Published in Mov Disord on January 31, 2011
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener (2012) 1.63
Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (2011) 1.51
Non-motor features of Parkinson disease. Nat Rev Neurosci (2017) 1.42
Genetically engineered mouse models of Parkinson's disease. Brain Res Bull (2011) 0.86
Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis. PLoS One (2014) 0.85
Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease. Aging Dis (2015) 0.80
Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model. Am J Nucl Med Mol Imaging (2013) 0.78
Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach. J Neurol (2013) 0.78
Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease. J Neural Transm (Vienna) (2016) 0.77
Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease. Acta Neurol Scand (2014) 0.77
Olfactory dysfunction is related to postoperative delirium in Parkinson's disease. J Neural Transm (Vienna) (2016) 0.77
Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein. PLoS One (2015) 0.77
Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor. Parkinsons Dis (2016) 0.75
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. P T (2015) 0.75
Identification of odorant-receptor interactions by global mapping of the human odorome. PLoS One (2014) 0.75
Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease. Sci Rep (2017) 0.75
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes. Genes Dev (2006) 4.97
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain (2007) 4.82
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol (2009) 3.91
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Retracted Small RNA duplexes function as mobile silencing signals between plant cells. Science (2010) 2.76
Unique functionality of 22-nt miRNAs in triggering RDR6-dependent siRNA biogenesis from target transcripts in Arabidopsis. Nat Struct Mol Biol (2010) 2.63
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology (2013) 2.52
Thinking of the future and past: the roles of the frontal pole and the medial temporal lobes. Neuroimage (2003) 2.51
Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring) (2008) 2.30
Asymmetric membrane ganglioside sialidase activity specifies axonal fate. Nat Neurosci (2005) 2.12
Arabidopsis RNA-dependent RNA polymerases and dicer-like proteins in antiviral defense and small interfering RNA biogenesis during Turnip Mosaic Virus infection. Plant Cell (2010) 2.02
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke (2006) 1.99
Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J (2013) 1.98
Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol (2005) 1.97
Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med (2011) 1.95
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology (2006) 1.95
Stage-specific expression of microRNAs during Xenopus development. FEBS Lett (2005) 1.92
Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res (2003) 1.91
On the origin of Acochlidia and other enigmatic euthyneuran gastropods, with implications for the systematics of Heterobranchia. BMC Evol Biol (2010) 1.85
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol (2013) 1.79
Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke (2002) 1.74
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry (2005) 1.71
NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest (2007) 1.70
Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem Cells (2008) 1.67
Does the human dorsal stream really process a category for tools? J Neurosci (2012) 1.63
Near-infrared spectroscopic topography as a tool to monitor motor reorganization after hemiparetic stroke: a comparison with functional MRI. Stroke (2002) 1.63
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener (2012) 1.63
Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol (2002) 1.62
Activity in the lateral prefrontal cortex reflects multiple steps of future events in action plans. Neuron (2006) 1.61
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol (2014) 1.60
Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair. Hum Mol Genet (2009) 1.59
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med (2003) 1.57
Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) (2008) 1.55
Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.55
The role of the basal forebrain in episodic memory retrieval: a positron emission tomography study. Neuroimage (2002) 1.51
The human prefrontal and parietal association cortices are involved in NO-GO performances: an event-related fMRI study. Neuroimage (2002) 1.51
Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci (2004) 1.49
High-frequency gamma-band activity in the basal temporal cortex during picture-naming and lexical-decision tasks. J Neurosci (2005) 1.48
Age-related changes in topological organization of structural brain networks in healthy individuals. Hum Brain Mapp (2011) 1.47
Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res (2010) 1.47
Human cerebral circulation: positron emission tomography studies. Ann Nucl Med (2005) 1.46
Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med (2006) 1.46
Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med (2008) 1.45
Familial inclusion body myositis: a report on two Japanese sisters. Intern Med (2003) 1.45
Accuracy of sonographic elastography in the differential diagnosis of enlarged cervical lymph nodes: comparison with conventional B-mode sonography. AJR Am J Roentgenol (2008) 1.43
Pure optic-spinal form of multiple sclerosis in Japan. Brain (2002) 1.41
MRI findings from a case of fulminating adult-onset measles encephalitis. Intern Med (2006) 1.40
Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis (2013) 1.40
Changes in the arterial fraction of human cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography. J Cereb Blood Flow Metab (2005) 1.39
A functional MRI study of simple arithmetic--a comparison between children and adults. Brain Res Cogn Brain Res (2004) 1.39
Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk Res (2005) 1.38
Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res (2002) 1.37
In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer (2005) 1.37
SGS3 and RDR6 interact and colocalize in cytoplasmic SGS3/RDR6-bodies. FEBS Lett (2009) 1.36
Relationship between fluoroscopic time, dose-area product, body weight, and maximum radiation skin dose in cardiac interventional procedures. AJR Am J Roentgenol (2006) 1.36
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med (2002) 1.34
Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis (2002) 1.34
Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS (2013) 1.33
Voxel-based morphometry of human brain with age and cerebrovascular risk factors. Neurobiol Aging (2004) 1.33
NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem (2003) 1.30
Cortical mechanisms of visual self-recognition. Neuroimage (2005) 1.30
Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem Biophys Res Commun (2003) 1.28
Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging (2005) 1.27
Deceiving others: distinct neural responses of the prefrontal cortex and amygdala in simple fabrication and deception with social interactions. J Cogn Neurosci (2007) 1.26
Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis (2004) 1.25
Characterization of Striped jack nervous necrosis virus subgenomic RNA3 and biological activities of its encoded protein B2. J Gen Virol (2005) 1.25
Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res (2006) 1.24
Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain (2012) 1.21
Representation of immediate and final behavioral goals in the monkey prefrontal cortex during an instructed delay period. Cereb Cortex (2005) 1.21
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med (2009) 1.21
Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics (2008) 1.21
Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med (2005) 1.20
Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem (2009) 1.19
Demonstration of the artery of Adamkiewicz at multi- detector row helical CT. Radiology (2002) 1.19
Dissociable roles of prefrontal and anterior cingulate cortices in deception. Cereb Cortex (2005) 1.18
Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res (2005) 1.18